{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:09:13Z","timestamp":1792804153742,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GQ1402"],"award-info":[{"award-number":["01GQ1402"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["AFI 13812"],"award-info":[{"award-number":["AFI 13812"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["NL-18002CB"],"award-info":[{"award-number":["NL-18002CB"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["01DN18022"],"award-info":[{"award-number":["01DN18022"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["IRTG 2150"],"award-info":[{"award-number":["IRTG 2150"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZUK32\/1"],"award-info":[{"award-number":["ZUK32\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.neubiorev.2019.12.019","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T12:46:03Z","timestamp":1576154763000},"page":"854-865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Neurochemical profiles in hereditary ataxias: A meta-analysis of Magnetic Resonance Spectroscopy studies"],"prefix":"10.1016","volume":"108","author":[{"given":"Janna","family":"Krahe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Binkofski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Reetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Romanzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neubiorev.2019.12.019_bib0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0361-9230(00)00321-X","article-title":"Proton magnetic resonance spectroscopy of patients with parkinsonism","volume":"52","author":"Abe","year":"2000","journal-title":"Brain Res. Bull."},{"issue":"5","key":"10.1016\/j.neubiorev.2019.12.019_bib0010","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mds.26181","article-title":"In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7","volume":"30","author":"Adanyeguh","year":"2015","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.neubiorev.2019.12.019_bib0015","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","article-title":"Spinocerebellar ataxias: prospects and challenges for therapy development","volume":"14","author":"Ashizawa","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12311-014-0610-3","article-title":"Consensus paper: radiological biomarkers of cerebellar diseases","volume":"14","author":"Baldar\u00e7ara","year":"2015","journal-title":"Cerebellum"},{"issue":"3","key":"10.1016\/j.neubiorev.2019.12.019_bib0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/nbm.3252","article-title":"Multi-center reproducibility of neurochemical profiles in the human brain at 7 Tesla","volume":"28","author":"van de Bank","year":"2015","journal-title":"NMR Biomed."},{"issue":"3","key":"10.1016\/j.neubiorev.2019.12.019_bib0030","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jmri.20846","article-title":"Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging","volume":"25","author":"Boesch","year":"2007","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1053-1807","key":"10.1016\/j.neubiorev.2019.12.019_bib0035","first-page":"553","article-title":"Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6","volume":"13","author":"Boesch","year":"2001","journal-title":"J. Magn. Reson."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.12.019_bib0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jmri.1078","article-title":"Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6","volume":"13","author":"Boesch","year":"2001","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000111347","article-title":"Multinuclear NMR studies on the energy metabolism of glial and neuronal cells","volume":"15","author":"Brand","year":"1993","journal-title":"Dev. Neurosci."},{"issue":"14","key":"10.1016\/j.neubiorev.2019.12.019_bib0050","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/00001756-200310060-00008","article-title":"Atrophy pattern in SCA2 determined by voxel-based morphometry","volume":"14","author":"Brenneis","year":"2003","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.12.019_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.10419","article-title":"Cardiac energetics correlates to myocardial hypertrophy in Friedreich\u2019s ataxia","volume":"53","author":"Bunse","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jinorgbio.2018.03.007","article-title":"Interactions of iron-bound frataxin with ISCU and ferredoxin on the cysteine desulfurase complex leading to Fe-S cluster assembly","volume":"183","author":"Cai","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40673-014-0017-4","article-title":"The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type","volume":"1","author":"Chen","year":"2014","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12311-012-0390-6","article-title":"Spinal cord atrophy correlates with disability in Friedreich\u2019 s Ataxia","volume":"12","author":"Chevis","year":"2013","journal-title":"Cerebellum"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/jnc.12216","article-title":"Diabetes in Friedreich ataxia","author":"Cnop","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0080","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2214\/ajr.164.6.7754871","article-title":"Perspective clinical MR spectroscopy: fundamentals, current applications, and future potential","author":"Cousins","year":"1995","journal-title":"Am. J. Roentgenol."},{"issue":"1","key":"10.1016\/j.neubiorev.2019.12.019_bib0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1552-6569.2008.00260.x","article-title":"Axonal dysfunction in the deep white matter in Machado-Joseph disease","volume":"19","author":"D\u2019Abreu","year":"2009","journal-title":"J. Neuroimaging"},{"issue":"3","key":"10.1016\/j.neubiorev.2019.12.019_bib0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1552-6569.2011.00614.x","article-title":"Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study","volume":"22","author":"D\u2019Abreu","year":"2012","journal-title":"J. Neuroimaging"},{"issue":"5","key":"10.1016\/j.neubiorev.2019.12.019_bib0095","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/mrm.25295","article-title":"Two-site reproducibility of cerebellar and brainstem neurochemical profiles with short-echo, single voxel MRS at 3 T","volume":"73","author":"Deelchand","year":"2015","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0100","first-page":"76408","article-title":"High field MRS is more sensitive to progression of neurodegeneration than clinical decline in spinocerebellar ataxia type 1 (SCA1) Target audience","volume":"22","author":"Deelchand","year":"2014","journal-title":"Proc. Intl. Soc. Mag. Reson. Med."},{"issue":"79","key":"10.1016\/j.neubiorev.2019.12.019_bib0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/jnnp.2007.124297","article-title":"Brain structural damage in Friedreich\u2019 s ataxia","volume":"7","author":"Della Nave","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.neubiorev.2019.12.019_bib0110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/acn3.315","article-title":"Cognition in Friedreich\u2019s ataxia: a behavioral and multimodal imaging study","volume":"3","author":"Dogan","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0115","first-page":"1","article-title":"Structural characteristics of the central nervous system in Friedreich ataxia: an in vivo spinal cord and brain MRI study","author":"Dogan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12311-008-0025-0","article-title":"Magnetic resonance imaging in spinocerebellar ataxias","author":"D\u00f6hlinger","year":"2008","journal-title":"Cerebellum"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12311-013-0527-2","article-title":"Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1","volume":"13","author":"Doss","year":"2014","journal-title":"Cerebellum"},{"issue":"8","key":"10.1016\/j.neubiorev.2019.12.019_bib0130","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00415-015-7788-2","article-title":"Cerebellar neurochemical alterations in spinocerebellar ataxia type 14 appear to include glutathione deficiency","volume":"262","author":"Doss","year":"2015","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neuroimage.2011.12.038","article-title":"The neurochemical profile quantified by in vivo 1H NMR spectroscopy","volume":"61","author":"Duarte","year":"2012","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12311-014-0619-7","article-title":"Spinal cord damage in Machado-Joseph disease","volume":"14","author":"Fahl","year":"2015","journal-title":"Cerebellum"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0145","series-title":"BEST (Biomarkers, EndpointS, and Other Tools) Resource","author":"FDA-NIH Biomarker Working Group","year":"2016"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000064927","article-title":"A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson\u2019s disease","volume":"14","author":"Firbank","year":"2002","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"7","key":"10.1016\/j.neubiorev.2019.12.019_bib0155","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00415-009-5079-5","article-title":"A combined voxel-based morphometry and 1H-MRS study in patients with Friedreich\u2019s ataxia","volume":"256","author":"Fran\u00e7a","year":"2009","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.12.019_bib0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s100720050035","article-title":"Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes","volume":"20","author":"Frederico","year":"1999","journal-title":"Ital. J. Neurol. Sci."},{"issue":"5-6","key":"10.1016\/j.neubiorev.2019.12.019_bib0165","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/nbm.1940020505","article-title":"Brain metabolites as1H NMR markers of neuronal and glial disorders","volume":"2","author":"Gill","year":"1989","journal-title":"NMR Biomed."},{"issue":"6","key":"10.1016\/j.neubiorev.2019.12.019_bib0170","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.neurobiolaging.2014.01.001","article-title":"Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies","volume":"35","author":"Graff-Radford","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.12.019_bib0175","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12311-016-0767-z","article-title":"Combined cerebellar proton MR spectroscopy and DWI study of patients with friedreich\u2019s Ataxia","volume":"16","author":"Gramegna","year":"2016","journal-title":"Cerebellum"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.12.019_bib0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmri.21804","article-title":"Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias","volume":"30","author":"Guerrini","year":"2009","journal-title":"J. Magn. Reson. Imaging"},{"issue":"8","key":"10.1016\/j.neubiorev.2019.12.019_bib0185","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/brain\/awh201","article-title":"Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study","volume":"127","author":"Guerrini","year":"2004","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0404.2011.01620.x","article-title":"MR spectroscopy and atrophy in Gluten, Friedreich\u2019s and SCA6 ataxias","volume":"126","author":"Hadjivassiliou","year":"2012","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.12.019_bib0195","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archneur.62.4.621","article-title":"Antioxidant Treatment of Patients With Friedreich Ataxia","volume":"62","author":"Hart","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0200","series-title":"Contemporary Clinical Neuroscience","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-319-33555-1_9","article-title":"Magnetic resonance spectroscopy in ataxias","author":"Henry","year":"2016"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0205","first-page":"6221","article-title":"MRS and diffusion MRI of the spinal cord in Friedreich\u2019s Ataxia","volume":"22","author":"Henry","year":"2014","journal-title":"Proc. Intl. Soc. Mag. Reson. Med."},{"issue":"September","key":"10.1016\/j.neubiorev.2019.12.019_bib0210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/bmj.3.5619.649","article-title":"Study of fatal cases of Friedreich\u2019 s Ataxia","volume":"3","author":"Hewer","year":"1968","journal-title":"Br. Med. J."},{"issue":"11","key":"10.1016\/j.neubiorev.2019.12.019_bib0215","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"7414","key":"10.1016\/j.neubiorev.2019.12.019_bib0220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br. Med. J."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0225","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.nicl.2018.03.013","article-title":"Resting-state connectivity in neurodegenerative disorders: Is there potential for an imaging biomarker?","volume":"18","author":"Hohenfeld","year":"2018","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0230","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.57.4.626","article-title":"Brain metabolite concentration and dementia severity in Alzheimer\u2019s disease","volume":"57","author":"Huang","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nicl.2016.11.007","article-title":"CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3","volume":"13","author":"Huang","year":"2017","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0240","first-page":"200","article-title":"1H MR spectroscopy in friedreich\u2019s Ataxia and Ataxia with oculomotor apraxia type 2","author":"Iltis","year":"2011","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neubiorev.2019.12.019_bib0245","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1474-4422(13)70104-2","article-title":"Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data","volume":"12","author":"Jacobi","year":"2013","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.12.019_bib0250","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.25212","article-title":"Neurochemical abnormalities in premanifest and early spinocerebellar ataxias","volume":"83","author":"Joers","year":"2018","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.12.019_bib0255","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3174\/ajnr.A4760","article-title":"MR imaging in Spinocerebellar ataxias: a systematic review","volume":"37","author":"Klaes","year":"2016","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","article-title":"Friedreich\u2019s ataxia: pathology, pathogenesis, and molecular genetics","volume":"303","author":"Koeppen","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0265","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/NEN.0b013e31827e5762","article-title":"Friedreich Ataxia : Neuropathology Revised","volume":"72","author":"Koeppen","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.neubiorev.2019.12.019_bib0270","first-page":"511","article-title":"Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3 \/Machado-Joseph disease","volume":"36","author":"Lei","year":"2011","journal-title":"J. Cent. South Univ."},{"issue":"10","key":"10.1016\/j.neubiorev.2019.12.019_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0047925","article-title":"Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy","volume":"7","author":"Lirng","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neubiorev.2019.12.019_bib0280","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.1001","article-title":"Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich\u2019s ataxia","volume":"49","author":"Lodi","year":"2001","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.neubiorev.2019.12.019_bib0285","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1007\/s00415-013-6998-8","article-title":"Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3","volume":"260","author":"Lopes","year":"2013","journal-title":"J. Neurol."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.12.019_bib0290","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s00415-008-0907-6","article-title":"Spinal cord atrophy in spinocerebellar ataxia type 3 and 6","volume":"255","author":"Lukas","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0295","doi-asserted-by":"crossref","DOI":"10.1007\/s12311-017-0854-9","article-title":"Spinal cord damage in spinocerebellar Ataxia type 1","author":"Martins","year":"2017","journal-title":"Cerebellum"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0300","first-page":"85","article-title":"Magnetic resonance and nuclear medicine imaging in ataxias","volume":"103","author":"Mascalchi","year":"2011","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.410430215","article-title":"Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1","volume":"43","author":"Mascalchi","year":"1998","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0310","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2232010722","article-title":"Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia","volume":"223","author":"Mascalchi","year":"2002","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.neubiorev.2019.12.019_bib0315","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/jmri.10189","article-title":"Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum","volume":"16","author":"Mascalchi","year":"2002","journal-title":"J. Magn. Reson. Imaging"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0320","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/nbm.1940040203","article-title":"A review of chemical issues in 1H NMR spectroscopy: N\u2010acetyl\u2010l\u2010aspartate, creatine and choline","volume":"4","author":"Miller","year":"1991","journal-title":"NMR Biomed."},{"issue":"9","key":"10.1016\/j.neubiorev.2019.12.019_bib0325","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/mds.23067","article-title":"Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status","volume":"25","author":"\u00d6z","year":"2010","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0330","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12311-010-0213-6","article-title":"Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy","volume":"10","author":"\u00d6z","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0335","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrn.2017.92","article-title":"Polyglutamine spinocerebellar ataxias \u2014 from genes to potential treatments","volume":"18","author":"Paulson","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0340","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1212\/WNL.0000000000006121","article-title":"Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich\u2019 s Ataxia Consortium for","volume":"91","author":"Reetz","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0345","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1522-2586(199905)9:5<711::AID-JMRI14>3.0.CO;2-3","article-title":"Aging of the Adult Human Brain : In Vivo Quantitation of Metabolite Content With Proton Magnetic Resonance Spectroscopy","volume":"716","author":"Saunders","year":"1999","journal-title":"J. Magn. Reson. Imaging"},{"issue":"3","key":"10.1016\/j.neubiorev.2019.12.019_bib0350","first-page":"40","article-title":"An R package for meta-analysis","volume":"7","author":"Schwarzer","year":"2007","journal-title":"R News"},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0355","doi-asserted-by":"crossref","DOI":"10.1038\/nature22044","article-title":"Antisense oligonucleotide therapy for spinocerebellar Ataxia type 2","volume":"544","author":"Scoles","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.12.019_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","article-title":"Brain pathology of spinocerebellar ataxias","volume":"124","author":"Seidel","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ana.410390111","article-title":"Proton magnetic resonance spectrscopic imaging in patients with cerebellar degeneration","volume":"39","author":"Tedeschi","year":"1996","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.12.019_bib0370","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mrm.26022","article-title":"Test-retest reproducibility of neurochemical profiles with short- echo, single voxel MRS at 3T and 7T","volume":"76","author":"Terpstra","year":"2016","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neubiorev.2019.12.019_bib0375","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0301-0082(95)00014-M","article-title":"N - Acetylaspartate in neuropsychiatric disorders","volume":"46","author":"Tsai","year":"1995","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.neubiorev.2019.12.019_bib0380","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/mds.25010","article-title":"Brain metabolite alterations and cognitive dysfunction in early Huntington\u2019s disease","volume":"27","author":"Unschuld","year":"2012","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.neubiorev.2019.12.019_bib0385","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.parkreldis.2004.02.006","article-title":"Characterization of ataxias with magnetic resonance imaging and spectroscopy","volume":"10","author":"Viau","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.12.019_bib0390","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2005.05.015","article-title":"1H magnetic resonance spectroscopy of autosomal ataxias","volume":"1049","author":"Viau","year":"2005","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.neubiorev.2019.12.019_bib0395","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0960-8966(00)00108-5","article-title":"Mitochondrial impairment of human muscle in Friedreich ataxia in vivo","volume":"10","author":"Vorgerd","year":"2000","journal-title":"Neuromuscul. Disord."},{"issue":"10","key":"10.1016\/j.neubiorev.2019.12.019_bib0400","doi-asserted-by":"crossref","first-page":"e47479","DOI":"10.1371\/journal.pone.0047479","article-title":"Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.12.019_bib0405","first-page":"103","article-title":"Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA\/Cr reduction in pontine base as a valuable diagnostic marker","volume":"75","author":"Watanabe","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2019.12.019_bib0410","first-page":"291","article-title":"Value of 1 H-MRS on SCA3 \/ MJD diagnosis and clinical course","volume":"42","author":"Xing","year":"2017","journal-title":"J. Cent. South. Univ. (Med Sci)"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976341930867X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976341930867X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:54:35Z","timestamp":1758966875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014976341930867X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":82,"alternative-id":["S014976341930867X"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.12.019","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurochemical profiles in hereditary ataxias: A meta-analysis of Magnetic Resonance Spectroscopy studies","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}